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ABSTRACT
Nursing homes and other long term health care facilities have traditionally been the
home of the frail aged or younger people with profound disabilities. With increases in
medical knowledge comes increased human longevity and diseases associated with
longer life will lead to an increase in number of people with dementia. As a sufferers
condition worsens, the idea of placement may arise, and the person is placed in a
nursing home where sufferers receive specialised care. As this happens expectations of
quality of care in long term care facilities will rise, and certain questions will need to be
addressed.
The aim of this study is to look at three of the more common forms of dementia -
Alzheimers disease (AD), multi infarct dementia (MID) and the lesser known AIDS
dementia complex (ADC).
ADC care is a relatively new concept to the majority of nursing homes mainly due to the
fact that powerful anti-viral drugs are being used as treatment, resulting in an increase
in the lifespan of sufferers. Due to the fact that placement in a long term care facility is
significantly cheaper than specialised home care, it is eminently possible that the
numbers of AIDS sufferers in nursing homes will also increase. This study will also
address the contentious issues associated with the placement of ADC sufferers in
nursing homes.
In the future studies such as this will be of utmost importance not only to the medical
field but to all allied health teams providing care in a nursing home or other long term
care facility.
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INTRODUCTION
The extension of the average human lifespan has resulted in a rising prevalence of
chronic disease in our population, and dementia is no exception to this. This study will
look at a brief overview of dementia and discusses the diagnosis, pathology, clinical
features, treatment and duration of Alzheimers disease (AD), multi infarct dementia
(MID) and acquired immune deficiency syndrome (AIDS) dementia complex (ADC).
Finally, the feasibility of care of ADC sufferers in long term care institutions will be
discussed.
In order to define dementia, it is important to realise that it is not merely a part of
growing old and is not necessarily associated with wrinkles and grey hair. Dementia
affects an estimated 5% of the population aged 65 and over, and 20% of the population
aged 75 and over (McLean, 1987).
Dementia is a syndrome, characterised by a series of separate signs and symptoms
which may be caused by underlying illnesses (Jacques, 1988). Each of these illnesses
should have a clear, definable underlying pathology - organic or psychological. The
presence of dementia may be the localising sign of an underlying pathology of some
sort.
McLean provides this lengthy definition:
"dementia is.....an acquired decline in a range of cognitive abilities (including
memory, learning, orientation and attention) and intellectual skill (including
abstraction, judgement, comprehension, language usage and calculation)
accompanied by alterations in personality and behaviour which impair daily
functioning, social skills and emotional control." (1987, p149)
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What McLean is suggesting is that dementia is a progressive and often irreversible loss
of mental function, until the person is no longer able to perform basic functions such as
eating or drinking. There are two main forms of dementia - that found in the younger
population of 75 years and below, the so called "young old", and the other found in
older patients of75 and over - the "old old" (Council on the Ageing, 1994). Dementia
may be further divided into two categories - cortical or subcortical, depending on the
part of the brain affected. The distinction between the two is a basic difference in the
pathological process causing the dementia and therefore the differing clinical outcomes
(McLean, 1987). Clinical features are also different - subcortical dementia is
characterised by a generalised mental slowing and apathy, while those suffering from
cortical dementia will often display an impairment in the higher cerebral functions such
as cognition.
Approximately 10% of dementia cases are caused by a number of other factors such as
acute infective illnesses, metabolic disorders or depression, which may lead to a
diagnosis of pseudodementia (Forsythe, 1990). Syphilis of a long standing nature may
also cause dementia, as well as brain tumors or chronic subdural haematoma (Forsythe,
1990).
For many years it has been known that a severe affective disorder could lead to some
form of cognitive impairment, hence the term pseudodementia. The syndrome of
pseudodementia refers to a variety of conditions where the clinical features point to a
form of dementia, but the underlying cause is a psychiatric illness. Interestingly
enough, the clinical picture of profound, progressive cognitive decline may be
indistinguishable from that seen in progressive, irreversible dementia. The depression
must then be treated - if the dementia symptoms recede, then it is feasible to say that the
problem is depression related. However, Gustafson (1975) reported that 30% and
Liston (1977) 25% of people ultimately diagnosed as having dementia presented with a
fIrst symptom of depression (cited in Siegal and Gershon, 1986). Indeed, van Dujin
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and Hoffman (1991) suggested that a history of medically treated depression was 80%
more common in those with AD than in controls. As well as those described above,
there are also many genetic disorders causing dementia such as Huntingtons chorea,
Picks disease and the rarer Jacob Creuztfeld disease (Forsythe,1990).
ALZHEIMERS DISEASE
Alzheimers disease (AD) is the most common form of dementia, accounting for almost
60% of all cases (McLean, 1987). AD is a cortical brain disease of unknown cause,
which leads to memory loss and ultimately death. There are certain risk factors, the
most important of wnich is old age. A family history of the disease puts a person at a
definite risk. Also at risk are sufferers of Down's syndrome, who develop the brain
changes of AD by the time they are forty years old, however the observable signs of the
dementia do not present until the person is much older. The reason for this is not
understood, however the genes on chromosome-21 (the gene affected in Down's
syndrome) appear to be implicated in Alzheimer brain changes (Department of Health,
Housing and Community Services (DHHCS), 1993). Other risk factors include head
trauma which means AD is more likely in those whp have received a blow on the head
sufficient to cause unconsciousness (van Dujin and Hoffman, 1991). The
environmental factor aluminium may also play a part in AD. Metals such as aluminium
are known to have have a damaging effect on nerve cells in the body, and it is feasible
that AD may be caused by some form of toxic buildup (Jaques, 1988).
MULTI INFARCT DEMENTIA
Vascular dementias are the second most frequent form of dementia, occurring in 25 -
33% of people with diagnosed dementia. The most common of these is MID (Metter
and Wilson, 1993). MID is characterised by certain parts of the brain dying due to tiny
infarcts in the blood vessels. Once an area of the brain dies it no longer works, hence
the loss of function. Where AD has an insidious onset, MID is characterised by an
abrupt onset. Both show similar rates of decline, however there is a greater mortality
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associated with MID (Metter and Wilson, 1993). There has been less research carried
out on the risk factors of MID than AD, however since vascular dementia is due to tiny
strokes it may be assumed that the risk factors are similar than those of stroke. Again,
old age and family history are factors, and so is race and geographic location. For
example, the incidence of vascular dementia is higher in Japan and China than in
Australia, Europe or North America. (1) Diabetes mellitus predisposes a person to
MID, as do high blood cholesterol levels. Sufferers of MID tend to have low levels of
the good form of cholesterol, high density lipoprotein cholesterol. The major risk
factor is hypertension, which on its own may have an adverse affect on the persons
memory, unrelated to its role in producing infarctions (Jorm, 1990).
AIDS DEMENTIA COMPLEX
As at the end of March 1991, there were 2 527 cases of AIDS in Australia, (Kernutt,
Price, Judd and Burrows, 1993) and the AIDS dementia complex (ADC) is an integral
part of this disease. This is a less common form of dementia, however as people with
HIV are living longer it is expected to become more common, (ADC used to be known
as human immunodeficiency virus (HIV) encephalopathy, but ADC is now generally
used). ADC is the most commonly reported psychiatric syndrome associated with HIV
infection, with over two-thirds of the mental abnormalities in AIDS patients found to be
signs of ADC (Pratt, 1991). Unlike AD and MID, ADC is a late manifestation of the
later stage of HIV infection, usually occurring after one or more opportunistic infections
(Farthing, Brown and Staughton, 1988). It is described as a distinct, relatively
stereotyped neurological disorder, complicating HN infection, and is characterised by a
constellation of cognitive, motor and behavioural symptoms (Nurnberg, Prudic and
Fiori, 1984). ADC affects approximately 4.2% of AIDS sufferers (Kernutt et al, 1993).
DEMENTIA INCIDENCE
Different studies report different rates of the prevalence of dementia in the community.
The one common thread is that the prevalence of dementia increases with age (DHHCS,
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1993). The risk of AD doubles with every 4.5 years of age after the age of 60, with the
risk of vascular dementia doubling for every 5.3 years of age after the age of 60
(DHHCS,1993). It is predicted that the incidence of dementia will continue to rise,
along with the ageing of the Australian population, and that there are far more cases of
dementia found in the "old-old" age group. Incidence figures are difficult to find
concerning ADC, however since it was recognized as an AIDS defining condition, the
number of cases has steadily risen from 1.1% of cases reported in 1987 to 4.2% in
1990 (Kernutt et al, 1993).
CLINICAL FEATURES
AD presents with memory disturbance, personality and behaviour change and general
intellectual decline. La Rue, Watson and Plotkin (1993) found that initial symptoms
included depression, confusion language and motor problems and getting lost. The
effects of the disease on the cerebral cortex are shown by the development of aphasia,
apraxia and agnosia in some cases, and the short term memory loss. They also suggest
that sufferers may be anxious and aggressive, and have paranoid delusions.
MID sufferers typically show an uneven distribution of deficits in memory and a certain
lability of emotions. This may lead to brief episodes of being sad, with outbursts of
weeping or laughter. Personality changes may include apathy, or an accentuation of
previous personality traits (DHHACS, 1993). Interestingly enough, it is possible for
features of both AD and MID to be present in the one individual - this is known as
mixed dementia, and it is very hard to determine which form of dementia presented
first.
On a fmal note, a feature of AD and MID concerns Cerebral Blood Flow (CBF) and
J
metabolic changes. Both have been noted to differ in these forms of dementia, with AD
showing a more uniform reduction in both, whilst MID is characterised by patchy areas
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of decreased CBF and metabolism. These changes may even precede the onset of
clinical symptoms.
Cognitively, symptoms of ADC may include difficulty in concentrating, and
generalised slowing (Gee and Moran, 1988, Kernutt et al, 1993). Motor function is
affected, especially balance and co-ordination, with ocular motility and slowing of rapid
successive and alternating movements of the fingers and wrists other features of the
disease (price and Brew, 1988). Generalised weakness of the legs and arms, leading to
end stage ataxia, urinary and faecal incontinence and tremors are all neurological signs
of dementia (Gee and Moran, 1988, Price et al, 1988)
PATHOLOGY
AD is characterised by a series of changes in the brain itself, including brain shrinkage
and degeneration of neurones leaving plaques and tangles, and is therefore only
positively confirmed at autopsy. Ventricles also become enlarged and sucH are widened
(Thornton, Davies and Tinklenberg, 1986).
Over the course of the disease, the cerebral hemispheres start to shrink (Jacques, 1988,
Forsythe 1990, Bloom, Lazerson and Hofstader, 1985). A Computer Tomography
(CT) scan will easily show this process in younger populations with AD, but in older
brains, age related changes make these more difficult to identify. Shrinkage occurs
mainly in the cerebral cortex, the grey matter (neurones) and may effect the white matter
(nerve fibres) (Jacques, 1988). It is not known why the death of these particular cells
cause cerebral gray matter to shrink. The most significant damage appears to be
centered on the frontal, parietal and temporal lobes (Jacques, 1988). Damage is to the
hippocampal region of the temporal lobes - this is the centre for short term memory
function, the loss of which is a feature of AD. As the disease progresses, the lobes of
the brain become less convoluted and the surface flattens. At the same time, the sucH
widen, and ventricles which circulate cerebro-spinal fluid (CSF) expand. It also seems
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that neurones, especially the endings and connections, degenerate leaving plaques and
tangles (Jacques, 1988). Plaques are microscopic changes in the brain that show up
under magnification with silver stains containing deteriorating nerve endings. Their
numbers are directly proportional to the degree of intellectual impairment in the sufferer,
and are found in areas of greatest shrinkage (Jacques, 1988). (2) Neurofibrillary tangles
meanwhile, are found inside the neuron (Forsythe 1990, Jacques 1988) and they appear
to be made up of the remains of the damaged part of the neuron itself. Whatever their
meaning, the mere existence of plaques and tangles indicates a reduction in the numbers
of functional nerve cell connections. Neurotransmitters in the brain are used to transmit
messages and acetyl-choline is known to be decreased in the brains of AD sufferers,
particularly in the all important hippocampus (Bloom et al, 1985, Jacques, 1988,
Forsythe, 1990). It is easy to see then that if the neurones die, or if chemical
messengers are not available, then the message will not be sent. The presence of AD
also effects other transmitters - noradrenali~e, gamma-aminobutyric acid and 5-
hydroxytriptamine show a lesser decline (Wesson Ashford and Zec, 1993, Jacques,
1988, Bloom et aI, 1984). The losses of these transmitters however, may still be
secondary to the agent causing the underlying neuronal destruction.
MID results from certain pathological changes occurring in the circulatory system.
This form of dementia is caused by the occurrence of multiple cerebral infarctions and
haemorrhage (Jacques, 1988). Indeed when one looks at the surface of the brain of an
MID sufferer, the cerebral cortex is covered with multiple, miniature areas of damage,
with the underlying brain tissue softened and the cells are seen to be dead or dying
(Forsythe, 1990; Jacques, 1988). MID appears to result from one of two causes - the
occlusion of blood' vessels with resulting infarction, or by haemorrhage into the brain.
Typically, the infarction is a result of thrombotic or embolic occlusion (Metter et al,
1993). Atherosclerosis, although not a direct cause of MID, may cause the arteries to
develop lesions which render them more susceptible to occlusion. Reasons for this are
not yet clear (Metter et al1993; Jacques, 1993). Metter et al (1993) on the other hand,
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suggests that MID patients with hypertension may develop lipohyalinosis in their
arteries. This results in a loss in the muscular layers of the artery, and the formation of
lacunes which may cause some of the damage.
MID is classified as a subcortical dementia, however there is a current push to divide it
into being both cortical and subcortical. Cortical forms result from infarctions in the
large vessels, whilst subcortical forms are from damage to medium or small vessels
(Metter et aI, 1993). Again, the degree of intellectual impairment is directly
proportional to the degree of cerebral softening. Repeated infarcts continue to cause
decline, however it is when larger infarcts occur that the stepwise decline occurs. A
sudden infarct may cause the brain to become slightly oedematous, leading to acute
confusion and disorientation (Jacques, 1988). Functional level may remain lowered for
weeks or months, providing no further damage occurs. The area of cortex not damaged
may go on working normally, however connection with damaged areas may mean that a
person has decreased use of a particular function.
In ADC, the damage to the brain is considerable. It is generally believed that dementia
is a direct result of central nervous system (CNS) infection by the HIV virus (Price and
Brew, 1988). It seems that HIV penetrates the blood-brain barrier shortly following
initial infection, thereby causing abnormalities in the white matter and subcortical areas
with vaculocation (formation ofvacuoles in the interior of the nerve cells), an increase
in the number of astrocytes, inflammation of lymphocytes and macrophages and
demyelination of white matter the most common findings (Price and Brew 1988; Gee
and Moran, 1988; Kemutt et al' 1993). It appears that the cerebral cortex is generally
spared in ADC. Other neurological findings include an almost universal result of
cerebral atrophy, with widened cortical sucH and enlarged ventricles - both may be
confirmed by either CT scan or Medical Resonance Imaging (MRI).
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DIAGNOSIS
The primary requirement for a diagnosis of a dementia of any type is evidence of a
decline in thinking sufficient to impair activity. This should be evident for a period of
six months or more. It is vital that a diagnosis of dementia be made on a series of
recognized guidelines such as the Diagnostic and Statistical Manual of Mental Disorders
(DSM) (Oxford Dictionary of Nursing, 1994). This manual has now been revised and
the current version is known as the DSM-III-R criteria. If diagnosis is made purely
from a general interview with the person concerned, it is possible that vital information
the DSM-III-R are designed to identify may be missed.
According to McLean, for a diagnosis of AD, the DSM-ill-R requires the presence of:
1. the dementia syndrome
2. an insidious onset
3. a uniformly progressive, deteriorating course. (McLean,1987)
The DHHCS (1993) adds to these, suggesting that there should also be absence of
evidence (historically or clinically) that the dementia could be caused by any other
cause, and that there be an absence of vascular impairment in the brain. This diagnosis
may be further supported by progressive deterioration in cortical skills - primarily
language, motor performance and perception (McLean, 1987). However, a positive
diagnosis of AD can only be made at autopsy, although experienced clinicians can make
a correct diagnosis in approximately 90% of cases. The diagnosis of MID again
according to McLean, follows almost the same criteria, again set out by the DSM-III-R :
1. presence of the dementia syndrome
2. a stepwise course with patchy cognitive deficits
3. focal neurological symptoms and signs
4. evidence of contributing cardiovascular disease (McLean,1987)
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Neurological findings often go hand in hand with the above, depending on the location
of the lesions caused by infarction. These may include sensory loss, agnosia, neglect
or aphasia (Metter et al, 1993). Metter et al (1993) suggest that probable vascular
dementia requires not only evidence of memory loss, but clinical (DSM-III-R) or
radiological evidence of cerebrovascular disease, as well as evidence of two or more
strokes, or a single stroke that may lead to the dementia.
As yet, DSM-III-R do not seem to have diagnostic criteria for ADC, however Pratt
(1991) suggests that one would need "Clinical findings of disabling cognitive and/or
motor dysfunction, a loss of behavioural developmental milestones, progressing over
weeks and months in absence of concurrent illness." (p260) However it seems clinical
evidence of HIV infection would also need to be confrrmed. These results should be
confirmed by CT scan or MRI for two reasons. Firstly, progressive multifocal
leucoencephalopathy and cytomegalovirus encephalitis - both opportunistic viral
infections - can mimic ADC. Secondly, ADC may vary in its presentation - it may be
mild with only a few features, or profound, leaving a totally unresponsive patient.
(Farthing, Brown and Staughton, 1988) The importance of a thorough assessment of a
potential dementia patient is evidenced by the fact that ADC may often be misdiagnosed
as AD (Kemutt et al, 1993) and that ADC may be the sole presenting feature of HIV
infection. (Kemutt et aI, 1993; Roth, 1989; Price and Brew, 1988; and Saura Walsh
and Whipple, 1990).
DURATION OF THE DISEASE
Dementing diseases, due to their progressive decline, will shorten a persons life
expectancy considerably. However the reasons for death differ. In AD, the cause of
death is a gradual "fading away", whereas in MID it usually relates to disorders of
arteries in other parts of the body so death often results from hypertensive problems, a
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major heart attack or a major stroke (Jaques, 1988, p26). In ADC, the major cause of
death is from opportunistic infections such as pneumonia (Pratt, 1991). From the point
of medical detection, Schoenberg, Okazaki and Kokomen (1981) reported that 93% of
general dementia sufferers survived one year, 14% survived 5 years and 16% survived
ten years.
Taking AD, MID and ADC separately, it is difficult to provide a definitive disease
duration, as there is little information on survival rates. The average life expectancy of
a person with AD is three to ten years after recognition and diagnosis of the disease
(Kemutt et al, 1993). Recent studies setting out to compare the survival rates of MID
and AD sufferers have indicated that survival is far poorer for the sufferers of MID
(Metter et al, 1993). There is surprisingly little information on the survival rates of
MID sufferers, but it is safe to assume that they survive less than the ten years of AD
sufferers. Early estimates of the survival of those with ADC, put it at one to nine
months once diagnosis had taken place (Kemutt et al, 1993, Navia, Cho, Petito, Price,
1986) however this is lengthened in people being treated with Zidovudine (AZT). It is
difficult to put a time frame on this population as individual differences in the speed of
decline make accurate predictions difficult.
TREATMENT
No cure currently exists for these three forms of irreversible dementia. However, it is
possible, through careful diagnosis and assessment to treat secondary signs and
symptoms.
There is no known way to prevent, halt or slow the AD process. There have been many
attempts, including mainly cholinergic neuro transmitter enhancement therapy however
no large study has recorded clinically significant improvements in core dementia
symptoms (Wesson Ashford et al, 1993). At one stage it was thought that people
suffering from MID who were given cYclandate, isoxsuprine and dihydroergotoxine -
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all of which appear to increase cerebral blood flow - helped to improve memory and
intellectual capacity after several months continual treatment. Unfortunately, there
appeared to be no correlation between degree of improvement in cerebral circulation
observed in radio-circulograms and level of improvement in psychometric test scores.
Naftidrofuryl, another substance, has also been tested, and it proved superior to
placebo in two controlled studies (Silverstone and Turner, 1974).
To treat ADC is nigh on impossible without treating AIDS itself, and the drug AZT is
primarily used for this. Of course it is eminently possible that one day we will be able
to halt or even reverse the dementia process, however a fundamental difficulty with this
type of treatment is that no therapy can reverse structural damage to the brain and by the
time dementia has occurred it appears we can do little to alter the damage.
Management of the sufferer is all important while there is still no cure, and when a
person presents with memory problems they should receive a full dementia evaluation
(Wells, cited Wesson Ashford et aI, 1993). This is generally carried out by a
multidisciplinary team who will carry out a psychiatric and physical examination, and a
social and environmental assessment prior to treatment. This is used to diagnose
medical conditions that may be contributing to the memory problems, to determine
whether the problem is treatable or untreatable and to determine the severity of the
dementia if it exists. The team will then make recommendations to the family or
guardian as to:
1. whether current medications should be stopped
2. whether current medications should be changed
3. whether a change in living situations is appropriate (ie institutionalisation).
4. modification of living situation
5. the feasibility of respite care. (Mace, 1988)
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Treatment of clinical features of dementia is most often carried out by chemical means,
but it is important to ensure that before a medication is added to a treatment program that
there will be no unwanted side effects. There are many types of medications used to
treat the features of AD such as antipsychotics to decrease paranoia, belligerence and
agitation, however Thornton et al (1986) suggest that these should be used with care
due to the fact that demented people are especially susceptible to orthostatic
hypertension. Antidepressants are useful, however assessment to discount
pseudodementia is important. Tranquillisers may also be useful to treat minor sleep
disturbances over a short period of time.
For those with MID, medications described above may be useful, as well as drugs to
treat hypertension. The referring medical officer must remember in a case like this that
several of the medications used to treat hypertension may have an adverse affect on
mental function. Beta blockers that cross the blood-brain barrier more slowly may be
safer more because they affect cognitive function variably (Thornton, et al, 1986).
No specific treatment for HN dementia currently exists, although there has been short
improvement in patients whose neurological changes were treated with the drug AZT
(Price and Brew, 1988, Grant and Heaton, 1990). This antiviral drug has certain
properties allowing it to cross the blood-brain barrier. Preliminary reports show that
AZT may be able to reverse some of the damage caused by ADC (Aggleton, Homans,
Mojsa, Watson and Watney, 1989) One of the side effects of AZT however, appears to
be amnesia, but the severity of this is not reported (The Albion St (AIDS) Centre,
1988). Other medication used to treat the myriad of infections of AIDS, while not
treating the ADC, will help to make the person more comfortable. At present there are
many newer anti-retro-viral drugs in various stages of development, with clinical trials
to begin shortly.
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INSTITUTION BASED CARE·
A potential problem may occur for people suffering from AIDS and ADC in that at
present hostels and nursing homes are primarily used for the care of people suffering
from AD and MID. In the future, the introduction of newer drugs to battle the AIDS
virus will mean that patients will be living longer (although their quality of life is
questionable). As such, the incidence of ADC will rise and it may be that nursing
homes will take the brunt of long term care, as many are specifically set up to deal with
the management of dementia. Long term care facilities such as nursing homes may be a
less attractive alternative to home care, but they are far less expensive than private
nursing care twenty four hours a day.
At present, there are very few long term care facilities caring for people with AIDS and
ADC, but this will need to change as the affected population grows. To do this, there
are several obstacles that would need to be overcome first. There is fear or
apprehension among staff in caring for an ADC patient, in institutions as well as in the
field, along with staff ignorance and bias. Even if staff are registered, (and one would
assume, therefore educated) there still may be problems as staff fear transmission.
Staff turnover may well rise as a result of family members becoming anxious about the
social stigma attached to HIV and related illness. This pressure may also result in
greater stress levels among staff members. A general fear of AIDS may also be seen to
be a deterrent in staff recruitment. Staff may also be generally unwilling to care for
those residents with ADC. Of course for staff to be working with ADC, it is vital that
they understand the disease, and therefore understand that transmission is very specific.
If transmission occurs the effect is devastating - the question should be asked whether
or not it is fair to expose anyone to that risk.
Level of resident population understanding of AIDS or ADC needs to be investigated,
with resident concerns and reactions being taken into account (Linsk, Cich and
Cianfrani, 1993). Public paranoia about AIDS and mv is a very real issue - anyone
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who has worked in a nursing home knows that news spreads like wildfire, and there
may be residents moved out of the nursing home because of this. It is important that
issues such as these be looked at by nursing home administration, management and
owners, and strategies set up to deal with the problem sooner rather than later.
As was suggested, the incidence of dementia will increase as Australia's population
ages and it is safe to suggest that as it does, the numbers of people with AD, MID and
ADC will increase as well. As we learn more about the pathology of dementia it is
possible that treatments will become more sophisticated and a cure may be found. It is
vital for those administering and managing long term care facilities to start to think
about the placement of ADC patients and to set up guidelines to govern these.
CONCLUSION
There are three types of dementia discussed in this paper - Alzheimers disease, multi
infarct dementia and the AIDS dementia complex. Although all deal with the brain,
each have different clinical features, pathology, duration and treatment and as such,
behavioural and medical management will also differ. As yet, no cure is available for
any of the three, but it is possible to treat the associated symptoms such as depression
with careful diagnosis and assessment. This must then be followed by professional
behavioural and chemical management of the person. The question of the placement of
ADC sufferers in nursing homes is one that needs discussion and may require education
of not only staff, but also other residents as well as their families and friends.
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FOOTNOTES
(l)Whereas AD is the major cause of dementia in Australia, Europe and North America,
MID is the major cause in Japan and China. This difference could well be diet as
opposed to racially related - the traditional Japanese diet tends to produces more strokes
than the traditional Western diet (Jorm, 1990).
(2) These changes are also found in the brains of undemented people, although in far
smaller numbers (Jacques, 1988).
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GLOSSARY
ACETYL-CHOLINE - a neurotransmitter released at the synapse of parasympathetic
nerves and neuromuscular joints (Oxford Dictionary of Nursing, 1994).
AGNOSIA - Total loss of the ability to recognise familiar object or persons as a result
of organic brain damage (Oxford Dictionary of Nursing, 1994).
APHASIA - an abnormal neurologic condition in which language function is defective
or absent because of injury to certain areas of the cerebral cortex (Oxford Dictionary of
Nursing).
APRAXIA - an impairment in the ability to perform purposeful acts or manipulate
objects (Oxford Dictionary of Nursing, 1994).
CYTOMEGALOVIRUS ENCEPHALITIS - a herpes like virus causing inflammation
of the brain (Mosbys Medical, Nursing and Allied Health Dictionary, 1990).
DIAPEDESIS - migration through the of blood capillaries into the tissue spaces. A
reaction of tissue to injury (Oxford Dictionary of Nursing, 1994).
5-HYDROXYTRIPTAMINE - also known as serotonin, it is a central nervous system
neurotransmitter
(Mosbys Medical, Nursing and Allied Health Dictionatry,1990).
GAMMA-AMINO BUTYRIC ACID - an ammino acid with neuro transmitter activity
found in the brain (Mosbys Medical, Nursing and Alllied Health Dictionary, 1990).
HEMOSIDERIN - an iron rich pigment that is the product of red cell haemolysis
(Oxford Dictionary of Nursing, 1994).
LACUNE - a small infarction or haemorrhage less than lcm in diameter (Oxford
Dictionary of Nursing, 1994).
LIPOHYALINOSIS - the end stage of subintimal accumulation of hyaline materials.
The media becomes split and dissected and microaneurysms form. Diapedesis occurs
through the wall of the vein, and hemosiderin filled macrophages accumulate. The
lumen of the vessel becomes stenotic then occluded with lacunar infarcts developing
(Mosbys Medical Nursing and Allied Health Dictionary, 1990).
MEDIA - the mid layer of the wall of a vein or artery (Oxford Dictionary of Nursing,
1994).
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MULTI -FOCAL LEUCOENCEPHALOPATHY - a disease caused by a virus which
spreads throughout the white matter of the brain. Deterioration is usually rapid with
symptoms of confusion, gross short term and long term memory impairment as well as
motor retardation (Albion St (AIDS) Centre, interview, 20 October, 1994).
ORTHOSTATIC HYPERTENSION - hypertension incurred when a person stands
(Oxford Dictionary of Nursing, 1994)
SUBINTIMAL - the area beneath the membrane that lines a blood vessel (Oxford
Dictionary of Nursing, 1994).
SUCLI - the gaps between the convolutions in the brain (Oxford Dictionary of Nursing,
1994)
STENOTIC - an abnormal narrowing of the opening of a blood vessel (Mosbys
Medical, Nursing and Allied Health Dictionary, 1990).
19
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
REFERENCES
Aggleton, P, Homans H, Mojsa J, Watson S, Watney S. (1989) AIDS: scientific and
social issues - a resource for health educators. Edinburgh:Churchill Llvingstone.
Albion St (AIDS) Centre (1987) The AIDS Manual (2nd edition) Sydney:Stateprint
Albion St (AIDS) Centre. (20 October, 1994) Interview with staff member.
Bloom, F, Lazerson, A and Hofstader, L. (1985) Brain. mind and behaviour. New
York:WH Freeman.
Council on the Ageing. (20 October, 1994) Interview with staff member, Sydney.
Department of Health Housing and Community Services. (1993) The problem of
dementia in Australia. (3rd edition) Canberra:Australian Government Printing Service
Farthing, CF, Brown, SE and Staughton RCD. (1988) The colour atlas of AIDS and
HIV disease. (2nd edition) London:Wolfe Medical Productions
Forsythe, Elizabeth. (1990) Alzheimers Disease - the long bereavement. London:Faber
and Faber Ltd
Gee, G and Moran, T. (1988) AIDS: Concepts in nursing practice Baltimore:Williams
and Wilkins
Grant I and Heaton, RK. (1990) Human immuno deficiency virus type 1 (HIV-l) and
the brain. Journal of Consulting and Clinical Psychology. 58(1), pp 22-30.
Jacques, A. (1988) Understanding dementia London:Churchill Livingstone
Jorm, AF (1990) The Epidemiology of Alzheimers and related disorders.
London:Chapman and Hall
Kernutt GJ, Price, AJ, Judd, FK and Burrows GD. (1993) Human immunodeficieny
virus infection, dementia and the older patient. Australian and New Zealand Journal of
Psychiatry, Vol 27, pp 9-19
La Rue, A, Watson, J and Plotkin, D. (1993) First symptoms of dementia: a study of
relatives reports. International Journal of Geriatric Psychiatry Vol 8 (3), pp 239-245.
20
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
Linsk N, Cich, P and Cianfrani, L. (1993) The AIDS Epidemic - challenges for
nursing homes. Journal of Gerontological Nursing, Vo119, ppll-22.
Mace, N. (1988) Strategies for managing people with dementia. In Altman H and
Altman N (Eds) (1988) Alzheimers and Parkinsons disease - recent advances in
research and clinical management. New York:Plenum Press
McLean, Steve. (1987) Assessing dementia: Part 1 - difficulties, definition and
differential diagnosis. Australian and New Zealand Journal of Psychiatry VoI2(2), pp
149-165.
Mosbys Medical, Nursing and Allied Health Dictionary (1990) Mannaging Editor-
Walter Glanze. St Louis:CV Mosby Co.
Metter, EJ and Wilson, RS. (1993) Vascular Dementias. In Parks, RW, Zec RP and
Wilson RS. (Eds) Neuropsychology of Alzheimers disease and other dementias. pp
417-432 New York:Oxford University Press.
Navia, BA, Cho ES, Petito CK, Price RW. (1986) The AIDS dementia complex: 11
Neuropathology. Annals of Neurology pp 525-535
Nurnberg, HG, Prudic, J, Fiori, M. (1984) Psychopathology complicating AIDS.
American Journal of Psychiatry, 141, pp 95-96.
Oxford Dictionary of Nursing (1994) Consultant Editor - Tanya McFerran.
Oxford:Oxford University Press
Pratt, Robert. (1991) (3rd edition) AIDS: a strategy for nursing care. London:Edward
Arnold.
Price RW and Brew B. (1988) Management of the neurologic complications of HIV
infection and AIDS. In MA Sade and PA Volberding (Eds) The medical management
of AIDS, pp 111-126 Philadelphia: WB Saunders Co.
Roth, Jay S. (1989) All about AIDS. London:Harwood Academic Publishers.
Saura Walsh, K, and Whipple, B. (1990) Older adults as an HIV positive risk group.
Journal of Gerontological Nursing Vo116, no2, pp 6 - 9.
Schoenberg, BS, Okazaki, H and Kokomen E. (1981) Reduced survival in patients
with dementia: a population study. Transaction of the American Neurological
Association. 106, pp 306-308
21
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
Siegal B, and Gershon, S. (1987) Dementia, Depression and Pseudodementia. In
Harvey Altman (Bd) Alzheimers disease - problems. prospects and perspectives. pp
29-44 New York:Plenum Press
Silverstone, T and Turner, P. (1974) Drug Treatment in Psychiatry - social and
psychological aspects of medical practice. London:Routledge and Kegan Paul.
Thornton, JE, Davies HD and Tinklenberg JR. (1986) Alzheimers disease syndrome.
Journal of Psychosocial Nursing VoI24(5), pp 16- 22.
van Dujin C and Hoffman, B. (1991) Risk factors for Alzheimers disease: a
collaborative re-analysis of case control studies. International Journal of Epidemiology
20, Supplement 2.
Wesson Ashford, J and Zec, RP. (1993) Pharmacological treatment in Alzheimers
disease. In RW Parks, RP Zec and RS Wilson (Bds) Neuropsychology of Alzheimers
disease and other dementias. New York:Oxford University Press.
22
